Introduction
Although radical prostatectomy can be performed with diminished morbidity due to improvement of surgical techniques, many patients will suffer from post-operative erectile dysfunction (ED). Even with preservation of both neurovascular bundles (NVB), the potency rates range between 30% and 71%. 1 -3 After resection of both neurovascular bundles, spontaneous erections adequate for intercourse are extremely rare. 4 Rat model studies performed in 1991 were able to demonstrate clearly that erectile function returns after denervation and placement of nerve grafts. Using a genitofemoral nerve graft after bilateral resection of 5 mm segments, Quinlan et al were the first to report the return of potency 4 months post-operatively. 5 In the same year, the authors investigated the ability of nerve growth factor (NGF) as well as the use of fetal amniotic membrane as an alternative growth matrix to enhance regeneration of ablated cavernous nerves. Their results suggested that the use of these materials could facilitate autonomic nerve regrowth. 6 Encouraged by these experimental studies, Walsh carried out a randomized blind study of nerve grafts in patients who underwent wide excision of the neurovascular bundle: in 12 men, six received a genitofemoral nerve graft and the other six served as controls. In a 5 y follow-up, he could not observe any difference in the recovery of sexual function in these two groups. 7 After this observation, he abandoned this technique. Years later, in March 1997, Kim et al 8 successfully performed the initial bilateral interposition grafts from the sural nerve to both cavernous nerves in a 57-y-old, sexually active man. Since then, more than 300 procedures have been performed at more then six centers and some patients have recovered after bilateral resection and grafts. 9 Recovery after unilateral grafts appears comparable to recovery with bilateral nerve preservation. 9 -11 In this preliminary study, we report our nerve grafting results from 12 pre-operatively potent patients undergoing radical prostatectomy and cystectomy with a mean follow-up of 16 months.
Materials and methods

Patient selection
All selected individuals were patients with prostate or bladder cancer (mean age 57.5 y) and normal pre-operative erectile function, documented in a patient interview and a score of 25 or above in the EF domain of the International Index of Erectile Function (IIEF). 12 They had not received neoadjuvant hormonal or radiation therapy. Patient characteristics are shown in Table 1 . The patients were counseled that the nerve grafting would be performed at the time of the radical prostatectomy and that return of function might not be apparent for many months. After informing the subjects about the risks of nerve grafting (infection and blood loss related to the increased duration of the procedure, hematoma, infection at the nerve donor site, pain, sensory deficit in the lateral aspect of the foot, neuroma formation), written consent was obtained.
Surgical technique
Kim et al 4, 8 have described the surgical technique extensively. The main steps are (a) preparation and resection of the neurovascular bundle(s), (b) harvesting the sural nerve, (c) placement of the graft, and (d) completion of the vesicourethral anastomosis. The microsurgical team performs the harvesting of the sural nerve during removal of the prostate by the Urologic Surgeon. Sufficient nerve even for bilateral grafting is obtained from one leg. A midline incision from the mid calf to the ankle is performed. The sural nerve is located at the lateral ankle. After identification of the sural nerve between the median and the lateral heads of the M. gastrocnemius, the dissection is performed in a retrograde fashion for the required length, which for a unilateral case is approximately 8 cm. A microsuction mat is helpful to keep the oozing bed of the resected prostate from obscuring vision. Additional laxity is placed in the graft so that the following expansion of the bladder will not cause excessive tension on the anastomosis.
Gentle handling of the nerve using microsurgical instruments is important. Loupes are preferred for the anastomosis because of the difficulty in getting a microscope into the pelvis at the proper angle to see the distal anastomosis juncture. Initially, harvesting the nerve was performed by an orthopaedic surgeon trained in microsurgery (MPR), but now the senior author routinely harvests the nerve and performs the anastomosis himself. In order to identify and prepare the NVB accurately, a 4Â loupe magnification was used. Since the NVB is a plexus of nerve fibers and vessels, a relatively bloodless field is essential for proper preparation. Before (cysto)-prostatectomy, proximal and distal marking sutures with 8-0 Prolene were placed. In order to identify the nerve stumps precisely, intraoperative nerve stimulation was performed using the CaverMap surgical aid (UroMed Corp., Norwood, MA, USA). 13 A reading of þ 2 or more was used to determine bundle stump location. These parameters were used consistently. The graft was then inserted in an inverted fashion and the alignment of fascicles was carried out using 8-0 Prolene sutures after placing the vesicourethal anastomotic sutures (Figure 1) . After tying the vesicoanastomotic sutures very carefully, a suction drain with minimal suction was placed away from the area of the graft. All patients received unilateral nerve grafts on the side where NVB involvement was palpable and was therefore resected. One patient, however, received a unilateral nerve graft after resection of both NVBs (patient no. 4, Table 1 ). The average additional operative time was 45 min. Histopathological examination of the prostatectomy specimens was performed according to the 1997 TNM classification. 14 
Post-operative care
The time to discharge to home was unaffected by the additional grafting procedure. Patients were encouraged to start therapy with sildenafil citrate or, in case of failure, intracavernous Alprostadil within the first postoperative month, since it could be demonstrated that immediate administration of these erectogenic agents is able to increase the recovery rate of spontaneous erections after radical prostatectomy. 15, 16 Patients with advanced pathologic parameters routinely received radiation or hormonal therapy in an adjuvant setting. Postoperatively, the patients presented for a follow-up visit every 3 months, which included an interview and the IIEF questionnaire.
Results
The procedure could not be performed in two patients (one with prostate cancer and one with bladder cancer). Due to extensive local disease, the distal stump was too short after resection; therefore, a tension free anastomosis was technically not possible in these patients. The outcome of the nerve grafting procedures is shown in Table 1 . The mean follow-up for the 12 men was 16.1 months (range 7 -28). Overall, four of the 12 patients were able to achieve spontaneous erections sufficient for intercourse with vaginal penetration, documented with a score of > 20 in the EF domain of the IIEF. The youngest (bladder cancer) patient (no. 12) reported erections 3 months postoperatively. The patient after bilateral NVB resection (no. 4) reported erections 20 months after the procedure. Patients nos. 1 and 2 returned to erectile function after 24 and 12 months, respectively. In addition, Patient no. 8 reported improving partial erections. Surgical margins were reported positive in five out of 10 patients with prostate cancer. The patients receiving adjuvant external beam radiation (nos 5 and 9), or hormonal therapy (no. 6) reported having no erections. The only postoperative complication was one superficial wound infection at the donor site, which could be managed conservatively.
Discussion
Although nerve grafting has found application in urology only during recent years, it is an otherwise well established medical procedure: sural nerve grafts have been used extensively with brachial plexus, facial nerve and peripheral nerve injuries. 17, 18 Although it is myelinated, the sural nerve becomes functionally demyelinated during grafting. 17 Whenever a tension free end-to-end nerve repair, as after resection of the NVB during prostatectomy, is not possible, a segment of a peripheral nerve can be used for implantation. The graft serves as a channel or conduit for the regenerating axons on the proximal side to reach the distal stump. It also serves as a source of Schwann cells and growth factors to help facilitate regeneration. 19 Important aspects of nerve grafting include the creation of a tension free repair, with a graft 10 -20% longer than the defect to compensate for the shrinkage, a graft slightly larger than the transected nerve ends to capture and channel regenerating axons, meticulous tissue handling and loupe magnification to avoid damage to the graft, and sparing use of nylon microsuture. 17 Since nerve grafts can be limited because of limited length and sensory deficits at the site of removal, vein grafts, muscle-vein grafts, synthetic tubes as well as porous conduits have been examined for their suitability to fill post-traumatic defects. 20 The main disadvantage of these grafts is that they can be used only for short distance defects. Furthermore, synthetic materials are not biodegradable and can lead to reactions of the surrounding tissue. Previous animal studies by Quinlan et al and Ball et al using the genitofemoral nerve demonstrated the ability of interposition nerve grafts to recover erectile function in the majority of denervated rats, as measured by mating studies and electric pelvic nerve stimulation. 3, 21 Improvement of erectile function was noted at 3 -4 months postoperatively. In humans, however, the procedure is technically more challenging, since the cavernous nerve is not a well-defined structure, but consists of multiple nerves, which are dispersed in a plexus surrounded by vessels. 15 In their recently published study, Kim et al 22 presented the return of varying degrees of erectile function in nine of 12 men undergoing radical retropubic prostatectomy with wide bilateral cavernous nerve resection and interposition of sural nerve grafts. 22 In their 1 y follow-up study, three men had rigid erections sufficient for intercourse. Tumescence was not reported until 5 months post-operatively, and the best erections were observed at 18 months. According to the authors, the realization of the full benefit of these grafts may not be appreciated until at least 24 -36 months postoperatively. In our study, similar results could be observed: three of the four men with return of erectile function improved 12 -24 months after the procedure. It is interesting to observe, however, that one man returned to erectile function 3 months post-operatively. One possible explanation for that could be his young age (36 y). It could be demonstrated that age is one of the factors predicting the recovery of sexual function after radical pelvic surgery. 7 To the knowledge of the authors, this is also the first reported patient with recovery of erectile function after radical cystoprostatectomy and unilateral sural nerve graft interposition after unilateral NVB resection.
Although the benefits of the more common unilateral nerve graft procedure are more difficult to document (some patients recover erectile function when a single nerve is preserved), the clear decrease in erectile function after unilateral NVB resection has been extensively described recently by Scardino and Kim. 9 In their series, men after unilateral nerve grafting had similar erectile function according to the International Index of Erectile function compared with those with both nerves preserved (78 vs 79%, respectively).
It should be pointed out that the use of sural nerve grafts has been controversial. In a recent review, Walsh expressed his scepticism about the value of nerve grafts in restoring sexual function in men who undergo wide excision of the NVB. 7 Some important issues addressed in this review are the concept of excision of the NVB on the side of the positive biopsy; the problem of invasion of both NVBs; the high probability of NVB preservation of most patients with localized prostate cancer; and the low probability of recovery of sexual function of patients with extensive extracapsular disease. The latter remains an important issue, since patients with locally advanced disease have a high risk of recurrence and, furthermore, will require adjuvant therapy, which further compromises erectile function.
Conclusions
Unilateral sural nerve grafts are technically feasible and associated with minimal morbidity in patients during radical prostatectomy and radical cystectomy. In this preliminary study with a mean follow-up of 16.1 months, four out of 12 patients after radical prostatectomy or radical cystectomy recovered spontaneous erections sufficient for intercourse. Recovery in three of the four men occurred after a time interval between 12 and 24 months. To the knowledge of the authors, this is the first report of a successful sural nerve graft in a radical cystectomy patient.
The choice of the ideal candidate for nerve graft procedures remains problematic, since properly performed, randomized studies are missing. Patient selection criteria for these procedures have to be optimized, results can be evaluated only after long follow-up periods, and the small number of presented series does not justify a general enthusiasm about this innovative surgical technique.
